Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ATM | Q13315 | 1/20 | 0.69 |
| ▸ | HCAR2 | Q8TDS4 | 4/20 | 0.69 |
| ▸ | TSHR | P16473 | 3/20 | 0.53 |
| ▸ | HPGD | P15428 | 1/20 | 0.53 |
| ▸ | MAPT | P10636 | 1/20 | 0.51 |
| ▸ | RAB9A | P51151 | 1/20 | 0.51 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.51 |
| ▸ | APP | P05067 | 4/20 | 0.50 |
| ▸ | NAAA | Q02083 | 1/20 | 0.50 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.47 |
| ▸ | HTT | P42858 | 2/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL182438 | 1.00 | ATM (0.69) | ATMHCAR2TSHRHPGDMAPT | |
| SCHEMBL5176603 | 0.98 | HCAR2 (0.70) | ATMHCAR2TSHRHPGDMAPT | |
| SCHEMBL111970 | 0.98 | HCAR2 (0.70) | ATMHCAR2TSHRHPGDMAPT | |
| SCHEMBL1337692 | 0.98 | HCAR2 (0.70) | ATMHCAR2TSHRHPGDMAPT | |
| SCHEMBL1067418 | 0.98 | HCAR2 (0.70) | ATMHCAR2TSHRHPGDMAPT | |
| SCHEMBL8523181 | 0.98 | HCAR2 (0.70) | ATMHCAR2TSHRHPGDMAPT | |
| SCHEMBL1337844 | 0.98 | HCAR2 (0.70) | ATMHCAR2TSHRHPGDMAPT | |
| SCHEMBL10566535 | 0.98 | HCAR2 (0.70) | ATMHCAR2TSHRHPGDMAPT | |
| SCHEMBL8029495 | 0.98 | HCAR2 (0.70) | ATMHCAR2TSHRHPGDMAPT | |
| SCHEMBL1067419 | 0.98 | HCAR2 (0.70) | ATMHCAR2TSHRHPGDMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 263 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-103415280-A | Cross-linked copolymer containing phosphorylcholine monomer and cosmetic composition containing the same | KCI LTD | 2013-11-27 | — | — | CN | claimed |
| CN-1938255-A | Preparation of acrylic acid derivatives from alpha or beta-hydroxy carboxylic acids | CIBA SPEC CHEM WATER TREAT LTD (GB) | 2007-03-28 | — | — | CN | claimed |
| CN-1091087-C | Method for preparing alcohols | FIRMENICH & CIE (CH) | 2002-09-18 | — | — | CN | claimed |
| US-6046127-A | MIXTURE COMPRISING A POLYMETHYLHYDROGENSILOXANE CARBONYL MOIETY REDUCING AGENT AND CATALYST COMPRISING TRANSITION METAL COMPOUND COMPLEXED TO METALLIC OR BORO REDUCING AGENT; CATALYST SELECTIVITY | FIRMENICH SA (CH) | 2000-04-04 | — | — | US | claimed |
| US-5831133-A | REDUCTION OF ALDEHYDES, KETONES, ESTERS AND LACTONES | FIRMENICH SA (CH) | 1998-11-03 | — | — | US | claimed |
| US-20260096991-A1 | BIODEGRADABLE MICROCAPSULES AND METHOD FOR THEIR PREPARATION | XAMPLA LTD (GB) | 2026-04-09 | — | — | US | disclosed |
| EP-4489592-B1 | BIODEGRADABLE MICROCAPSULES AND A METHOD FOR THEIR PREPARATION | XAMPLA LTD (GB) | 2025-12-24 | — | — | EP | disclosed |
| US-20250255827-A1 | BIODEGRADABLE MICROCAPSULES AND A METHOD FOR THEIR PREPARATION | XAMPLA LIMITED (GB) | 2025-08-14 | — | — | US | disclosed |
| US-20250186960-A1 | BIODEGRADABLE MICROCAPSULES AND A METHOD FOR THEIR PREPARATION | XAMPLA LIMITED (GB) | 2025-06-12 | — | — | US | disclosed |
| EP-3888782-B1 | COATED MICROCAPSULES | NOXELL CORP (US) | 2025-06-11 | — | — | EP | disclosed |
| US-20250177298-A1 | EMULSIONS AND A METHOD FOR THEIR PREPARATION | XAMPLA LIMITED (GB) | 2025-06-05 | — | — | US | disclosed |
| WO-2025109106-A1 | CORE-SHELL MICROCAPSULES | XAMPLA Ltd. (GB) | 2025-05-30 | — | — | WO | disclosed |
| CN-1020612-C | METHOD FOR PREPARING ANTIHYPERTENSIVE TRICYCLIC LACTAM DERIVS. | MERRELL PHARMA INC (US) | 1993-05-12 | — | — | CN | disclosed |
| EP-0226387-A2 | Coating resin composition | Hitachi Chemical Co., Ltd. (JP) | 1987-06-24 | — | — | EP | disclosed |
| EP-0110309-B1 | PROCESS FOR THE PREPARATION OF 1,4-DIACYLOXY-1,3-BUTADIENES | BASF Aktiengesellschaft (DE) | 1986-02-19 | — | — | EP | disclosed |
| EP-0110309-A1 | Process for the preparation of 1,4-diacyloxy-1,3-butadienes | BASF Aktiengesellschaft (DE) | 1984-06-13 | — | — | EP | disclosed |
| US-4323363-A | DISPERSE DYE USED ON POLYESTERS MIXED WITH CELLULOSE | CASSELLA AKTIENGESELLSCHAFT (DE) | 1982-04-06 | — | — | US | disclosed |
| US-4100225-A | ANTISOILANT | CIBA-GEIGY CORPORATION (US) | 1978-07-11 | — | — | US | disclosed |
| US-4075237-A | Perfluorinated esters of fumaric acid and certain other ethylenically unsaturated poly-basic acid and soil repellant polymers thereof | GEIGY CHEMICAL CORPORATION (US) | 1978-02-21 | — | — | US | disclosed |
| US-4008293-A | ACRYLIC COPOLYMER, AMINOPLAST, BINDER | PPG INDUSTRIES, INC. (US) | 1977-02-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260096991-A1 | BIODEGRADABLE MICROCAPSULES AND METHOD FOR THEIR PREPARATION | PCTP, CLK4, MTCL3 | ATM 420/4885HCAR2 4673/4885TSHR 2408/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.